Tarsus Pharmaceuticals, Inc. ($TARS)
Filing Information
| Accession Number | 0001405253-26-000007 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 19, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
6,430
Total Value
$439,566.05
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer and Chief Strategy Officer | Common Stock | โ | Mar 17, 2026 | Sale | 2,111 | $69.42 | $146,545.62 | 47,635 | Direct | โ | View Details | |
Chief Financial Officer and Chief Strategy Officer | Common Stock | โ | Mar 18, 2026 | Sale | 2,133 | $68.71 | $146,558.43 | 45,502 | Direct | โ | View Details | |
Chief Financial Officer and Chief Strategy Officer | Common Stock | โ | Mar 19, 2026 | Sale | 2,186 | $67.00 | $146,462.00 | 43,316 | Direct | โ | View Details |